Literature DB >> 12558414

Iron-mediated preparation of vinylcyclopropanecarboxylates: scope, mechanism, and applications.

Young K Yun1, Kamil Godula, Yeyu Cao, William A Donaldson.   

Abstract

The addition of stabilized carbon nucleophiles to tricarbonyl(1-methoxycarbonylpentadienyl)iron(1+) cation (1a) proceeds via attack at C2 on the face of the ligand opposite the Fe(CO)(3) group to generate tricarbonyl(pentenediyl)iron complexes 2. Oxidation of complexes 2 affords vinylcyclopropanecarboxylates in good yield. In general, the relative stereochemistry about the cyclopropane ring reflects reductive elimination with retention of configuration. In cases where the C2 substituent is bulky (i.e., 2b) the major cyclopropane product 9b represents ring closure with inversion at C3. A mechanism involving pi-sigma-pi rearrangement of the initially oxidized (pentenediyl)iron species is proposed to account for these results. Experiments which probe the stereochemistry of deuterium labeling in the vinyl group of the vinylcyclopropanecarboxylate products were carried out, and these results are consistent with the proposed mechanism. This methodology for the preparation of vinylcyclopropanecarboxylates was applied to the synthesis of 2-(2'-carboxycyclopropyl)glycines (+)-22 and (-)-23 and the cyclopropane triester (-)-26.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558414     DOI: 10.1021/jo020421u

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Recent Applications of Acyclic (Diene)iron Complexes and (Dienyl)iron Cations in Organic Synthesis.

Authors:  William A Donaldson; Subhabrata Chaudhury
Journal:  European J Org Chem       Date:  2009-08

2.  Reactivity of (1-methoxycarbonylpentadienyl)iron(1+) cations with hydride, methyl, and nitrogen nucleophiles.

Authors:  Yuzhi Ma; Young K Yun; Julie Wondergem Nee Lukesh; Anobick Sar; Jayapal Reddy Gone; Sergey Lindeman; William A Donaldson
Journal:  Tetrahedron       Date:  2017-06-15       Impact factor: 2.457

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.